Gastrointestinal Conditions: Gastroesophageal Reflux Disease

Area of Science:

• Gastroenterology
• Internal Medicine

Background:

• Gastroesophageal reflux disease (GERD) is a common condition affecting over 20% of adults.
• Key risk factors include older age, obesity, smoking, and a sedentary lifestyle, with lower esophageal sphincter (LES) dysfunction being a primary cause.

Purpose of the Study:

• To review the diagnosis, management, and emerging treatments for GERD.
• To highlight the risks associated with GERD and the appropriate use of pharmacotherapy and lifestyle modifications.

Main Methods:

• Review of current literature on GERD diagnosis and treatment.
• Discussion of pharmacologic options including proton pump inhibitors (PPIs) and newer agents like vonoprazan.
• Exploration of lifestyle modifications and procedural interventions for GERD management.

Main Results:

• Classic GERD symptoms like heartburn and regurgitation can be treated with PPIs, ideally taken on an empty stomach.
• Patients with atypical symptoms or refractory disease may require esophagogastroduodenoscopy (EGD) and pH/impedance testing.
• Vonoprazan demonstrates superiority over traditional PPIs, and lifestyle changes are crucial for effective management.

Conclusions:

• GERD management requires a tailored approach, considering symptom presentation and treatment response.
• There is a need to judiciously use PPIs and consider tapering therapy when indicated.
• Emerging pharmacotherapies and procedural interventions offer additional options for patients with GERD.